Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 4

Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma

Total article views   HTML views PDF downloads Totals
5,944 Dovepress* 5,944+ 2,331 8,275
Totals 5,944 2,331 8,275
*Since 8 August 2008
+Since July 2016

View citations on Google Scholar